These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 35346132)

  • 1. The trend of 10-year cardiovascular risk among diabetic and non-diabetic participants in Tehran Lipid and glucose study: 1999-2018.
    Koohi F; Kohansal K; Naz MSG; Derakhshan S; Azizi F; Khalili D
    BMC Public Health; 2022 Mar; 22(1):596. PubMed ID: 35346132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 12-year trends in cardiovascular risk factors (2002-2005 through 2011-2014) in patients with cardiovascular diseases: Tehran lipid and glucose study.
    Rabani S; Sardarinia M; Akbarpour S; Azizi F; Khalili D; Hadaegh F
    PLoS One; 2018; 13(5):e0195543. PubMed ID: 29768511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trajectories of cardiovascular disease risk and their association with the incidence of cardiovascular events over 18 years of follow-up: The Tehran Lipid and Glucose study.
    Koohi F; Ahmadi N; Hadaegh F; Safiee S; Azizi F; Khalili D
    J Transl Med; 2021 Jul; 19(1):309. PubMed ID: 34271961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term incidence of cardiovascular outcomes in the middle-aged and elderly with different patterns of physical activity: Tehran lipid and glucose study.
    Naseri P; Amiri P; Masihay-Akbar H; Jalali-Farahani S; Khalili D; Azizi F
    BMC Public Health; 2020 Nov; 20(1):1654. PubMed ID: 33148219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Twelve-Year Cardiovascular and Mortality Risk in Relation to Smoking Habits in Type 2 Diabetic and Non-Diabetic Men: Tehran Lipid and Glucose Study.
    Hadaegh F; Derakhshan A; Mozaffary A; Hasheminia M; Khalili D; Azizi F
    PLoS One; 2016; 11(3):e0149780. PubMed ID: 26930192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucose intolerance and risk of cardiovascular disease in Iranian men and women: results of the 7.6-year follow-up of the Tehran Lipid and Glucose Study (TLGS).
    Hadaegh F; Khalili D; Fahimfar N; Tohidi M; Eskandari F; Azizi F
    J Endocrinol Invest; 2009 Oct; 32(9):724-30. PubMed ID: 19574728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Trend of Risk for Cardiovascular Diseases During the Past Decade in Iran, Applying No-Lab and Lab-Based Prediction Models.
    Fahimfar N; Kohansal K; Asgari S; Ostovar A; Hadaegh F; Khalili D
    Glob Heart; 2023; 18(1):3. PubMed ID: 36846721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid measures for prediction of incident cardiovascular disease in diabetic and non-diabetic adults: results of the 8.6 years follow-up of a population based cohort study.
    Tohidi M; Hatami M; Hadaegh F; Safarkhani M; Harati H; Azizi F
    Lipids Health Dis; 2010 Jan; 9():6. PubMed ID: 20096127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A 10-Year Cardiovascular Risk in Adults with Different Levels of Spiritual Health: Tehran Lipid and Glucose Study.
    Amiri P; Ghadirian F; Parvin P; Cheraghi L; Khalili D; Alamdari S; Azizi F
    Glob Heart; 2023; 18(1):1. PubMed ID: 36760804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive accuracy of the 'Framingham's general CVD algorithm' in a Middle Eastern population: Tehran Lipid and Glucose Study.
    Bozorgmanesh M; Hadaegh F; Azizi F
    Int J Clin Pract; 2011 Mar; 65(3):264-73. PubMed ID: 21314863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in cardiovascular risk factors among U.S. men and women with and without diabetes, 1988-2014.
    Sun X; Du T
    BMC Public Health; 2017 Nov; 17(1):893. PubMed ID: 29166886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between glucose intolerance status and risk of hospitalization during two decades of follow-up: Tehran lipid and glucose study.
    Rasooli R; Ramezankhani A; Khalili D; Tohidi M; Hasheminia M; Azizi F; Hadaegh F
    Ann Med; 2022 Dec; 54(1):3258-3268. PubMed ID: 36382719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Weight fluctuation, mortality, and cardiovascular disease in adults in 18 years of follow-up: Tehran Lipid and Glucose Study.
    Mehran L; Honarvar M; Masoumi S; Khalili D; Amouzegar A; Azizi F
    J Endocrinol Invest; 2023 Jan; 46(1):37-49. PubMed ID: 35921037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lifetime risk of cardiovascular disease stratified by traditional risk factors: Findings from the cohort of Tehran lipid and glucose study.
    Ramezankhani A; Azizi F; Hadaegh F
    Hellenic J Cardiol; 2023; 73():36-46. PubMed ID: 36914096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The 10-year trend of adult diabetes, prediabetes and associated risk factors in Tehran: Phases 1 and 4 of Tehran Lipid and Glucose Study.
    Mahtab N; Farzad H; Mohsen B; Nakisa D
    Diabetes Metab Syndr; 2017; 11(3):183-187. PubMed ID: 27666004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Dietary Diabetes Risk Reduction Score With Risk of Cardiovascular Diseases in the Iranian Population: Tehran Lipid and Glucose Study.
    Asghari G; Farhadnejad H; Teymoori F; Emamat H; Shahrzad MK; Habibi-Moeini AS; Mirmiran P; Azizi F
    Heart Lung Circ; 2022 Jan; 31(1):101-109. PubMed ID: 34176740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in cardiovascular disease risk factors in people with and without diabetes mellitus: a Middle Eastern cohort study.
    Jahangiri-Noudeh Y; Akbarpour S; Lotfaliany M; Zafari N; Khalili D; Tohidi M; Mansournia MA; Azizi F; Hadaegh F
    PLoS One; 2014; 9(12):e112639. PubMed ID: 25461381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimizing cardiovascular disease mortality prediction: a super learner approach in the tehran lipid and glucose study.
    Darabi P; Gharibzadeh S; Khalili D; Bagherpour-Kalo M; Janani L
    BMC Med Inform Decis Mak; 2024 Apr; 24(1):97. PubMed ID: 38627734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global cardiovascular mortality risk in the adult Polish population: prospective assessment of the cohorts studied in multicentre national WOBASZ and WOBASZ Senior studies.
    Piotrowski W; Waśkiewicz A; Cicha-Mikołajczyk A
    Kardiol Pol; 2016; 74(3):262-73. PubMed ID: 26365939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular risk and all-cause mortality attributable to diabetes: Tehran lipid and glucose study.
    Bozorgmanesh M; Hadaegh F; Sheikholeslami F; Azizi F
    J Endocrinol Invest; 2012 Jan; 35(1):14-20. PubMed ID: 21586894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.